Government data shows https://dashboard.cowin.gov.in that only 10% of about 12.6 million people immunized in India have taken the COVAXIN shot, which was found to be 81% effective in an interim...

Vaccine major Bharat Biotech on Wednesday said its COVID-19 vaccine, Covaxin, has demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials.

On the same day Brazil reached the grim milestone of 250,000 deaths by COVID-19, the country''s health ministry signed a deal with Indian pharmaceutical company Bharat Biotech for the purchase of 20...

Mathematical calculations indicate that Covaxin may provide immunity against Covid-19 for 9 to 12 months, and there may be a booster shot after this period elapses, Y.K. Gupta, the President of AIIMS...

Even as vaccine drive has entered the second leg under which frontline workers, including police personnel, are to be administered the shot, there still are very few takers for Covaxin.

The Centre said on Saturday that around 55 per cent of health care workers have been vaccinated in the country so far whereas nearly 5 per cent of frontline workers have received the Covid vaccine...

India has so far supplied COVID- 19 vaccine to 15 countries and another 25 nations are in the queue at different levels for the jab, External Affairs Minister S Jaishankar said here on Saturday.

The Tamil Nadu health department has announced in a statement that 1.57 lakh people in the state have been inoculated in 20 days since the drive begun from January 16.

The Union Health Ministry on Friday asked all states and UTs to initiate vaccination of frontline workers against COVID-19 from the first week of February.

Covaxin has been accorded approval for restricted emergency use in the country by the Drugs Controller General of India (DCGI) on January 3.